Improving Glycemic
Control Among
Indian Patients…
At Wellthy Therapeutics, our mission is
to inspire and enable 10 million patients
to reverse, prevent or control their
chronic condition by 2030.
Dr. Vinod Mattoo, Abhishek Shah, Pradeep Talwalkar, Girish Parmar, Sarita Bajaj,
Dr. Brij Mohan Makkar, Arjun Krishnakumar
India has the highest burden of type 2 diabetes. Lack of adequate knowledge and awareness contribute to
poor diabetes self-management, which lead to poor glycemic control and increase in diabetes complications.
We evaluate the effectiveness of the Wellthy CARETM (WC) digital therapeutic in changing behaviour
to improve outcomes in patients with diabetes.
Wellthy CARE™ (WC) is a digital therapeutic that delivers an artificial intelligence (AI) augmented disease
management program for people with diabetes.
We used de-identified data from 124 participants enrolled in the 16-week WC digital therapeutic.
The WC app provides coaching in the form of lessons and quizzes, and an AI based digital persuasion model to encourage users to self-report data on blood glucose, weight, meals, and physical activity, with active feedback on each data point. The participants also had access to a human health coach via chat and calls who helped them further personalise management.
The program was developed in lines with the AADE7™ guidelines and in collaboration with the RSSDI